$ENDP Endo International plc Forecasted to Post Q4 2018

$ENDP Endo International plc Forecasted to Post Q4 2018 Earnings of $0.60 Per Share (ENDP)



Endo International plc (NASDAQ:ENDP) (TSE:ENL) – Leerink Swann raised their Q4 2018 earnings per share (EPS) estimates for shares of Endo International in a research note issued on Monday, April 16th, Zacks Investment Research reports. Leerink Swann analyst A. Fadia now anticipates that the company will post earnings of $0.60 per share for the quarter, up from their previous estimate of $0.56. Leerink Swann has a “Outperform” rating and a $12.00 price objective on the stock. Leerink Swann also issued estimates for Endo International’s FY2022 earnings at $1.75 EPS.

A number of other equities analysts have also recently issued reports on ENDP. Vetr upgraded Endo International from a “buy” rating to a “strong-buy” rating and set a $8.92 price objective for the company in a report on Tuesday, December 26th. ValuEngine cut Endo International from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. Mizuho restated a “buy” rating and set a $12.00 target price (down from $14.00) on shares of Endo International in a report on Wednesday, January 3rd. Cantor Fitzgerald set a $7.00 target price on Endo International and gave the company a “hold” rating in a report on Thursday, January 11th. Finally, BidaskClub cut Endo International from a “hold” rating to a “sell” rating in a report on Thursday, January 11th. Four investment analysts have rated the stock with a sell rating, sixteen have given a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $9.40.

ENDP opened at $5.64 on Wednesday. Endo International has a 12-month low of $5.27 and a 12-month high of $14.15. The company has a debt-to-equity ratio of 17.00, a current ratio of 1.02 and a quick ratio of 0.85. The stock has a market capitalization of $1,232.84, a PE ratio of 1.47 and a beta of 0.38.
Endo International (NASDAQ:ENDP) (TSE:ENL) last posted its quarterly earnings data on Tuesday, February 27th. The company reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.62 by $0.15. Endo International had a positive return on equity of 81.03% and a negative net margin of 58.68%. The firm had revenue of $768.64 million during the quarter, compared to analysts’ expectations of $762.29 million. During the same period in the prior year, the business earned $1.77 EPS. The company’s revenue for the quarter was down 38.1% compared to the same quarter last year.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ENDP. Quantitative Investment Management LLC bought a new position in Endo International during the 4th quarter valued at approximately $1,569,000. River & Mercantile Asset Management LLP raised its position in shares of Endo International by 32.7% in the 4th quarter. River & Mercantile Asset Management LLP now owns 475,650 shares of the company’s stock worth $3,679,000 after acquiring an additional 117,110 shares in the last quarter. Amundi Pioneer Asset Management Inc. raised its position in shares of Endo International by 235.6% in the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 96,033 shares of the company’s stock worth $745,000 after acquiring an additional 67,415 shares in the last quarter. Alps Advisors Inc. raised its position in shares of Endo International by 22.9% in the 4th quarter. Alps Advisors Inc. now owns 307,839 shares of the company’s stock worth $2,386,000 after acquiring an additional 57,328 shares in the last quarter. Finally, Cornerstone Capital Management Holdings LLC. raised its position in shares of Endo International by 64.0% in the 3rd quarter. Cornerstone Capital Management Holdings LLC. now owns 135,627 shares of the company’s stock worth $1,160,000 after acquiring an additional 52,927 shares in the last quarter. 94.72% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “Endo International plc Forecasted to Post Q4 2018 Earnings of $0.60 Per Share (ENDP)” was originally posted by Week Herald and is the property of of Week Herald. If you are reading this article on another publication, it was illegally copied and republished in violation of United States & international trademark and copyright law. The legal version of this article can be read at https://weekherald.com/2018/04/25/leerink-swa...-endp.html.
About Endo International

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.

Get a free copy of the Zacks research report on Endo International (ENDP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com



Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.

(c) 2018 Week Herald Distributed by Newstex, LLC

The views expressed in any and all content distributed by Newstex and its re-distributors (collectively, the "Newstex Authoritative Content" are solely those of the respective author(s) and not necessarily the views of Newstex or its re-distributors. Stories from such authors are provided "AS IS," with no warranties, and confer no rights. The material and information provided in Newstex Authoritative Content are for general information only and should not, in any respect, be relied on as professional advice. Newstex Authoritative Content is not "read and approved" before it is posted. Accordingly, neither Newstex nor its re-distributors make any claims, promises or guarantees about the accuracy, completeness, or adequacy of the information contained therein or linked to from such content, nor do they take responsibility for any aspect of such content. The Newstex Authoritative Content shall be construed as author-based content and commentary. Accordingly, no warranties or other guarantees are offered as to the quality of the opinions, commentary or anything else appearing in such Newstex Authoritative Content. Newstex and its re-distributors expressly reserve the right to delete stories at its and their sole discretion.


Source: Online Publications (April 25, 2018 - 9:39 AM EDT)

News by QuoteMedia
www.quotemedia.com